The transaction
Sila Realty Trust agreed on April 20 to be acquired by affiliates of Blue Owl Real Estate Capital in an all-cash transaction valued at approximately $2.4 billion. Shareholders are to receive $30.38 per share.
That represents a 19.0 percent premium to Sila's closing price of $25.53 on April 17, the last trading day before the announcement, and a 25.6 percent premium to its 30-day volume-weighted average price.
Sila is a net-lease REIT specialising in healthcare property. Its chief executive, Michael A. Seton, and Blue Owl's co-president and global head of real assets, Marc Zahr, were both quoted in the announcement, which was issued from Tampa and New York. As of March 31, 2026, Sila's portfolio consisted of 137 properties totaling approximately 5.3 million rentable square feet, 98.7 percent leased, with a weighted-average remaining lease term of 10.1 years, a weighted-average fixed rent escalation rate of 2.1 percent excluding CPI-linked leases, and 24.9 percent of annualized base rent set to mature within five years.
Why net lease, why healthcare, why now
Net-lease healthcare is the closest thing commercial real estate offers to a credit instrument. Tenants sign long leases, pay operating costs directly and are difficult to relocate because of the capital sunk into clinical fit-out. The income stream behaves less like property and more like a corporate bond with an inflation link.
The gap between the one-day premium (19.0 percent) and the 30-day premium (25.6 percent) indicates Sila's shares had already been rising into the announcement, likely on deal speculation, which narrows what the headline premium alone can be read to say about relative valuation.
For Blue Owl, which has built a large alternative-asset platform spanning credit and real assets, a permanent-capital healthcare portfolio fits a strategy of owning contractual cash flows rather than trading assets. Sila reported first-quarter 2026 net income of $12.4 million, cash net operating income of $46.3 million, and adjusted funds from operations of $33.5 million, or $0.61 per diluted share, and had a liquidity position of approximately $465.8 million as of March 31, comprising $30.8 million in cash and $435.0 million of undrawn capacity.
Vote, closing and status
Sila's board unanimously approved the deal and recommended shareholders vote for it. At a special meeting held June 26, 2026, more than 98 percent of votes cast — representing approximately 63 percent of shares outstanding as of the record date — approved the merger, the companies said in a joint announcement. The transaction closed July 1, 2026, with Sila's common stock delisted from the NYSE.
Analysis: readers should treat announced per-share premiums with some care, since they are measured against a market price that already reflects speculation and the announcing parties choose the comparison window. What is verifiable here — the price, the vote result and the closing date — all came to pass as stated; the deal is complete.